Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
CA 2289731 A1 · Owner: Liang, Bruce T. · Inventors: Liang, Bruce T.; Jacobson, Kenneth A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions and methods for reducing or preventing ischemic damage of the heart are disclosed. A preferred embodiment of the invention comprises the simultaneous administration of specific A3/A1 receptor agonists to patients , suffering from ischemic damage or at risk for the same. In yet another embodiment of the invention, a binary conjugate which acts as an agonist for the A3 receptor and an antagonist at the A2a receptor is administered to , reduce or prevent ischemic damage to the heart.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 8, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 8, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 8, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.